Stevens-Johnson syndrome (SJS), also called erythema multiforme major, is a systemic disease mostly involving the skin and mucous ... and mucous membrane lesions. Vesiculo-bullous diseases such ...

The supplemental biologics license application for Dupixent for the treatment of bullous pemphigoid in ... blisters and rashes to form on the skin. These lesions are prone to infection as they ...

Bullous pemphigoid (BP), which has no FDA-approved targeted therapies, leads to reddening of the skin and the formation of painful and intensely itchy chronic lesions and blisters, in some cases ...

First up is the ADEPT study in bullous pemphigoid (BP), a rare skin condition that leads to reddening of the skin and the formation of painful and intensely itchy chronic lesions and blisters ...

Positive results from the ADEPT Phase II/III study indicate that Dupixent (dupilumab) may be effective in treating ...

Combomed Pharma is proud to announce the launch of Crystaderm™, an over-the-counter pharmaceutical product designed to effectively treat acne and impetigo. With its innovative formula, Crystaderm™ ...

Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times ... and characterized by intense itch and blisters, reddening of the skin, and painful lesions. Victoria ...

Dupilumab has been accepted for priority review by the US Food and Drug Administration (FDA) for the treatment of bullous pemphigoid ... by blisters, lesions, and skin reddening, as well as ...

Positive results from ADEPT phase 2/3 study of Dupixent in adults with moderate-to-severe bullous pemphigoid presented at AAD: Paris Tuesday, March 11, 2025, 14:00 Hrs [IST] Posit ...

reddening of the skin and painful lesions. “People with bullous pemphigoid live with unrelenting itch, blisters and painful lesions that can be debilitating and make it difficult to function daily.